Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Infection
1.2.4. End-use
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. Application
2.2.3. Infection
2.2.4. End-use
2.3. Competitive Insights
Chapter 3. U.S. Remote Patient Monitoring System Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of diseases such as diabetes
3.2.1.2. Technological advancements in healthcare
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations & approvals
3.3. U.S. Remote Patient Monitoring System Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. U.S. Remote Patient Monitoring System Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Remote Patient Monitoring System Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Vital sign monitors
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Blood pressure monitors
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Pulse oximeters
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Heart rate monitor (ECG)
4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Temperature monitor
4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.6. Respiratory rate monitor
4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.7. Brain monitoring (EEG)
4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Specialized monitors
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Anesthesia monitors
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Blood glucose monitors
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.4. Cardiac rhythm monitor
4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.5. Respiratory monitor
4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.6. Fetal heart monitors
4.4.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.7. Prothrombin monitors
4.4.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.8. Multi parameter monitors (MPM)
4.4.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.9. Others (Ventilators, Infusion Pumps and others)
4.4.2.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Remote Patient Monitoring System Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Remote Patient Monitoring System Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Cancer
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Cardiovascular diseases
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Diabetes
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Sleep disorder
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Weight management and fitness monitoring
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Bronchitis
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7. Infections
5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8. Virus
5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.9. Dehydration
5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.10. Hypertension
5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Remote Patient Monitoring System Market: Infection Estimates & Trend Analysis
6.1. Infection Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Remote Patient Monitoring System Market by Infection Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Eye infections
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Sinus infections
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Strep throat
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Remote Patient Monitoring System Market: End-use Estimates & Trend Analysis
7.1. End-use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. U.S. Remote Patient Monitoring System Market by End-use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Hospital-based patients
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Ambulatory patients
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Home healthcare
7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. Welch Allyn
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Smiths Medical
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Abbott
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Boston Scientific Corporation
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Dräger Medical
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. GE Healthcare
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Honeywell
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Johnson & Johnson
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. LifeWatch
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Medtronic
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. remote patient monitoring system market, by product, 2018-2030 (USD Million)
Table 3 U.S. remote patient monitoring system market, by infection, 2018-2030 (USD Million)
Table 4 U.S. remote patient monitoring system market, by application, 2018-2030 (USD Million)
Table 5 U.S. remote patient monitoring system market, by end-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 U.S. remote patient monitoring system market: Market outlook
Figure 9 Remote patient monitoring system competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 U.S. remote patient monitoring system market driver impact
Figure 14 U.S. remote patient monitoring system market restraint impact
Figure 15 U.S. remote patient monitoring system market: Product movement analysis
Figure 16 U.S. remote patient monitoring system market: Product outlook and key takeaways
Figure 17 Vital sign monitors market estimates and forecasts, 2018-2030 (USD Million)
Figure 18 Blood pressure monitors market estimates and forecasts, 2018-2030 (USD Million)
Figure 19 Pulse oximeters market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Heart rate monitor (ECG) market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Temperature monitor market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Respiratory rate monitor market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Brain monitoring (EEG) market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Specialized monitors market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Anesthesia monitors market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Blood glucose monitors market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Cardiac rhythm monitor market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Respiratory monitor market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Capnographs market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Spirometers market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Fetal heart monitor market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Prothrombin monitors market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Multi parameter monitors market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 U.S. remote patient monitoring system market: Application movement analysis
Figure 36 U.S. remote patient monitoring system market: Application outlook and key takeaways
Figure 37 Cancer market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Cardiovascular diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Diabetes market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Sleep disorder market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Weight management and fitness monitoring market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Bronchitis market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Infections market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Virus market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Dehydration market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Hypertension market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 U.S. remote patient monitoring system market: Infection movement Analysis
Figure 48 U.S. remote patient monitoring system market: Infection outlook and key takeaways
Figure 49 Eye infections market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Sinus infections market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Strep throat market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 U.S. remote patient monitoring system market: End-use movement analysis
Figure 53 U.S. remote patient monitoring system market: End-use outlook and key takeaways
Figure 54 Hospital-based patients market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Ambulatory patients market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Home healthcare market estimates and forecasts, 2018-2030 (USD Million)